Sample Collection Mechanism and Sampling Reproducibility - Screening Sample Clauses

Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide information concerning the reproducibility of the OF specimen collection mechanism supplied with the drug testing system. Please complete the attached table. xxxx redacted text xxxx
Sample 1
AutoNDA by SimpleDocs
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide information concerning the volume of OF used for an on-site drug screening test using the system: What volume of OF is used for the on-site screening test? How critical is the volume used for the on-site test?. Please complete the attached table using validation studies. xxxx redacted text xxxx
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide information on the recovery of drugs of abuse from the oral fluid collection mechanism.
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide information concerning the volume of undiluted OF which can be supplied to a laboratory confirmatory analysis after completion of the on-site screening test. Please complete the attached table. xxxx redacted text xxxx
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please supply information concerning the cross-reactivity of the system in relation to: Morphine / Codeine / 6-Monoacetyl / <Morphine / Dihydrocodeine / Cocaine / Benzoylecgonine Please complete the attached table. Please supply a list of cross-reactivities (on a separate attachment) to show how the drug testing system reacts with any other medicinal drugs tested (see Para 1, Annex A, Part 2 of the specification). Please supply a list (on a separate attachment) of any substances you have tested for possible interference with the screening test (e.g. food, beverages, sweets, toothpaste, herbal preparations etc) and indicate whether any reactivity was observed. xxxx redacted text xxxx
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. What is the accuracy (sensitivity and specificity) of the drug testing system? Please supply information/evidence which substantiates this (see Para 1, Annex A, Part 2 of the specification).
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide any information/evidence to substantiate the recommended storage conditions of the oral fluids sample to be submitted for confirmatory analysis (see Para 9, Annex A, Part 3 of the specification). Concateno UK xxxx redacted text xxxx.
Sample 1
AutoNDA by SimpleDocs
Sample Collection Mechanism and Sampling Reproducibility - Screening. Please provide details of how your organisation plans to maintain continuity of performance and minimise the risks of variation between batches of on-site test reagents throughout the period of the contract.
Sample 1
Sample Collection Mechanism and Sampling Reproducibility - Screening. Any components of the drug testing system which are in contact with the oral fluid sample (for example, indicator dye, buffer solution, containers) must not detrimentally contaminate, adulterate or otherwise alter the sample. Please supply information/evidence which substantiates this. Concateno UK All of the DDS components have been thoroughly tested during the development of the system and do not affect either the screening or confirmation processes. This is evidenced by the fact that as the incumbent supplier to DIP, the DDS has been in use since 2008 and no sample contamination, adulteration or otherwise has been seen. There have been no issues caused during the GC/MS confirmation runs during this time. The DDS collector was designed in conjunction with the buffer system to release drugs and drug metabolites from the collection swab. To demonstrate that the collection device does not affect the result (i.e. shows high drug recovery/low adsorption) saliva samples were fortified with drug at the lowest concentration likely to trigger a positive and submitted through the entire DDS process. xxxx redacted text xxxx This was repeated across 5 different donor saliva samples for each drug/drug metabolite under test. xxxx redacted text xxxx
Sample 1

Related to Sample Collection Mechanism and Sampling Reproducibility - Screening

  • Loop Testing/Trouble Reporting 2.1.6.1 Think 12 will be responsible for testing and isolating troubles on the Loops. Think 12 must test and isolate trouble to the BellSouth portion of a designed/non- designed unbundled Loop (e.g., UVL-SL2, UCL-D, UVL-SL1, UCL-ND, etc.) before reporting repair to the UNE Customer Wholesale Interconnection Network Services (CWINS) Center. Upon request from BellSouth at the time of the trouble report, Think 12 will be required to provide the results of the Think 12 test which indicate a problem on the BellSouth provided Loop.

  • Follow-up Testing An employee shall submit to unscheduled follow-up drug and/or alcohol testing if, within the previous 24-month period, the employee voluntarily disclosed drug or alcohol problems, entered into or completed a rehabilitation program for drug or alcohol abuse, failed or refused a preappointment drug test, or was disciplined for violating the provisions of this Agreement and Employer work rules. The Employer may require an employee who is subject to follow-up testing to submit to no more than six unscheduled drug or alcohol tests within any 12 month period.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Meter Testing Company shall provide at least twenty-four (24) hours' notice to Seller prior to any test it may perform on the revenue meters or metering equipment. Seller shall have the right to have a representative present during each such test. Seller may request, and Company shall perform, if requested, tests in addition to the every fifth-year test and Seller shall pay the cost of such tests. Company may, in its sole discretion, perform tests in addition to the fifth year test and Company shall pay the cost of such tests. If any of the revenue meters or metering equipment is found to be inaccurate at any time, as determined by testing in accordance with this Section 10.2 (Meter Testing), Company shall promptly cause such equipment to be made accurate, and the period of inaccuracy, as well as an estimate for correct meter readings, shall be determined in accordance with Section 10.3 (Corrections).

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Drug Testing Procedures a. The testing procedures and safeguards provided in this policy shall be adhered to by any laboratory personnel administering departmental drug tests.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work.

  • Standard Samples Bid Specifications may indicate that the Product to be purchased must be equal to a standard sample on display in a place designated by the Commissioner and such sample will be made available to the Bidder for examination prior to the opening date. Failure by the Bidder to examine such sample shall not entitle the Bidder to any relief from the conditions imposed by the Bid Specifications.

Time is Money Join Law Insider Premium to draft better contracts faster.